A Deep Dive into a Amarin (AMRN) Takeover, Other Scenarios
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
NCE Decision Again Upon Amarin (AMRN); Could Be a 5-Bagger in a Takeover
October 5, 2012 1:41 PM EDTWith shares of Amarin Corporation (NASDAQ: AMRN) down over 20 percent in the past few months investors may be thinking the market has missed the fact that the FDA approved the company's Vascepa for very high triglycerides in July. But the truth is - it didn't. The ever-allusive NCE status has been the culprit... More
